Protocol for the examination of specimens from patients with gastrointestinal stromal tumor.

Authors Brian P. Rubin, MD, PhD, FCAP* Departments of Anatomic Pathology and Molecular Genetics, Cleveland Clinic, Lerner Research Institute and Taussig Cancer Center, Cleveland, Ohio Charles D. Blanke, MD, FACP British Columbia Cancer Agency and University of British Columbia, Vancouver British Columbia, Canada George D. Demetri, MD Dana-Farber Cancer Institute, Boston, Massachusetts Ronald P. Dematteo, MD Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York Christopher D. M. Fletcher, MD, FRCPath Department of Pathology, Brigham and Women’s Hospital, Boston, Massachusetts John R. Goldblum, MD Department of Anatomic Pathology, Cleveland Clinic, Cleveland, Ohio Jerzy Lasota, MD, PhD Department of Soft Tissue Pathology, Armed Forces Institute of Pathology, Washington DC Alexander J. Lazar, MD PhD, FCAP Department of Pathology, Sarcoma Research Center, The University of Texas MD Anderson Cancer Center, Houston, Texas Robert G. Maki, MD, PhD Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York Markku Miettinen, MD, PhD Department of Soft Tissue Pathology, Armed Forces Institute of Pathology, Washington DC Amy Noffsinger, MD Department of Pathology, University of Chicago Medical Center, Chicago, Illinois Mary Kay Washington, MD, PhD, FCAP Department of Pathology, Vanderbilt University Medical Center, Nashville, Tennessee Thomas Krausz, MD, FRCPath† Department of Pathology, University of Chicago Medical Center, Chicago, Illinois For the Members of the Cancer Committee, College of American Pathologists